NCT03678987View on ClinicalTrials.gov

Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

September 13, 2018

Primary Completion Date

January 1, 2020

Study Completion Date

February 1, 2020

Conditions
Systemic SclerosisGastrointestinal Complication
Interventions
DIAGNOSTIC_TEST

P-MPA concentration

We will calculate AUC\_0-12 of MPA based on 4 measurements of P-MPA

DRUG

mycophenolic acid

Patient will ingest mycophenolic acid as prescribed by their physician under the surveillance of an investigator.

Trial Locations (1)

221 85

Reumatologi SUS Lund, Region Skåne, Lund

All Listed Sponsors
lead

Region Skane

OTHER

NCT03678987 - Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis | Biotech Hunter | Biotech Hunter